TP53 and hepatocellular carcinoma: In the TP53 cancer pathway HBx upregulation of miR-181a contributes to increasing HCC proliferation by downregulated E2F5 expression [247], as well as facilitating HCC survival by suppressing FAS to promote an anti-apoptotic response [246].